TABLE 5.
Diagnoses of kidney diseases based on renal biopsies comparing the COVID-19 lockdown period 2020 with the same period in 2019.
| Diagnosis | March/April 2020 | March/April 2019 | P value |
| Total – no. | 14 | 20 | |
| ANCA GN – no. (%) | 3 | 4 | |
| Acute interstitial nephritis – no. (%) | 1 | 2 | |
| IgA nephropathy – no. (%) | 3 | 1 | |
| Diabetic nephropathy – no. (%) | 3 | 2 | |
| FSGS – no. (%) | 0 | 1 | |
| Lupus nephritis – no. (%) | 0 | 3 | |
| IgA vasculitis – no. (%) | 1 | 0 | |
| Membranous GN – no. (%) | 0 | 1 | |
| Postinfectious GN – no. (%) | 1 | 0 | |
| Thrombotic microangiopathy – no. (%) | 1 | 1 | |
| Amyloidosis – no. (%) | 0 | 1 | |
| Monoclonal immune deposition disease – no. (%) | 0 | 1 | |
| Others/not representative – no. (%) | 1 | 3 | 0.5325 |
Non-parametric between-group-comparisons were performed with Pearson’s Chi-square test. ANCA, anti-neutrophil cytoplasmic antibodies; BUN, blood urea nitrogen; CRP, C-reactive protein; FSGS, focal segmental glomerulosclerosis; GN, glomerulonephritis; IgA, immunoglobulin A; IQR, interquartile range; No., number.